Xiangliang Yuan Selected Research

Xiangliang Yuan Research Topics

Disease

14	Neoplasms (Cancer) 01/2023 - 06/2014
6	Stomach Neoplasms (Stomach Cancer) 11/2020 - 08/2016
4	Neoplasm Metastasis (Metastasis) 01/2020 - 06/2013
2	Colorectal Neoplasms (Colorectal Cancer) 07/2017 - 06/2015
2	Inflammation (Inflammations) 02/2015 - 10/2012
2	Hepatitis B 10/2013 - 01/2013
1	Cryopyrin-Associated Periodic Syndromes 12/2023
1	Hypersensitivity (Allergy) 10/2022
1	Melanoma (Melanoma, Malignant) 01/2022
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 01/2020
1	Colitis 01/2019
1	Stomach Diseases 10/2017
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2015
1	Leukemia 02/2015
1	HIV Infections (HIV Infection) 02/2014
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 02/2014
1	Urinary Bladder Neoplasms (Bladder Cancer) 06/2013
1	Paraproteinemias (Monoclonal Gammopathy) 01/2013
1	Multiple Myeloma 01/2013
1	Acute Coronary Syndrome 10/2012

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 01/2023 - 08/2016
3	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2019
3	B7-H1 AntigenIBA 11/2020 - 10/2017
2	ApolipoproteinsIBA 01/2023 - 01/2018
2	Apolipoproteins E (ApoE)IBA 01/2023 - 01/2018
2	Transcription Factors (Transcription Factor)IBA 01/2020 - 06/2013
2	Biomarkers (Surrogate Marker)IBA 01/2018 - 07/2017
2	Formaldehyde (Formol)FDA Link 10/2017 - 06/2015
2	ParaffinIBA 10/2017 - 06/2015
2	Activating Transcription Factor 3IBA 07/2017 - 06/2013
2	GelsolinIBA 08/2016 - 06/2013
1	InflammasomesIBA 12/2023
1	Adenosine Triphosphatases (ATPase)IBA 01/2023
1	Immunoglobulins (Immunoglobulin)IBA 01/2023
1	LigandsIBA 01/2023
1	Histamine (Histamine Dihydrochloride)FDA Link 10/2022
1	Histamine Receptors (Histamine Receptor)IBA 10/2022
1	Histamine Antagonists (Antihistamines)IBA 10/2022
1	purineIBA 01/2022
1	Inosine FDA Link 01/2022
1	Vitamin E FDA LinkGeneric 01/2022
1	Protein Tyrosine PhosphatasesIBA 01/2022
1	Tamoxifen FDA LinkGeneric 01/2021
1	Estrogen ReceptorsIBA 01/2021
1	2- (1H- indazol- 4- yl)- 6- (4- methanesulfonylpiperazin- 1- ylmethyl)- 4- morpholin- 4- ylthieno(3,2- d)pyrimidineIBA 01/2021
1	Aromatase InhibitorsIBA 01/2021
1	Protein Isoforms (Isoforms)IBA 11/2020
1	LipidsIBA 11/2020
1	Phosphatidylinositols (Phosphatidylinositol)IBA 11/2020
1	CateninsIBA 01/2020
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2020
1	MethyltransferasesIBA 01/2020
1	KinesinsIBA 01/2020
1	Blocking AntibodiesIBA 01/2020
1	CytokinesIBA 01/2020
1	IpilimumabIBA 01/2019
1	NivolumabIBA 01/2019
1	Programmed Cell Death 1 ReceptorIBA 01/2019
1	ChromatinIBA 07/2017
1	RNA (Ribonucleic Acid)IBA 07/2017
1	Cisplatin (Platino)FDA LinkGeneric 01/2017
1	Antiviral Agents (Antivirals)IBA 02/2015
1	Toll-Like Receptors (Toll-Like Receptor)IBA 02/2015
1	Fatty Acid Synthases (Fatty Acid Synthase)IBA 06/2014
1	Fatty Acids (Saturated Fatty Acids)IBA 06/2014
1	Intravenous Immunoglobulins (IVIG)FDA Link 02/2014
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 10/2013
1	Hepatitis B e AntigensIBA 10/2013
1	B-Cell Activating FactorIBA 01/2013
1	ParaproteinsIBA 01/2013
1	Interleukin-17 (Interleukin 17)IBA 10/2012
1	OsteopontinIBA 10/2012

Therapy/Procedure

7	Immunotherapy 01/2023 - 01/2018
7	Therapeutics 01/2022 - 02/2015
1	Drug Therapy (Chemotherapy) 01/2017
1	Microspheres (Microsphere) 10/2013
1	Lasers (Laser) 10/2013
1	Quantum Dots (Quantum Dot) 01/2013